Inventor · disambiguated record
James P. Beck
Also filed as: BECK JAMES · BECK JAMES P · BECK JAMES PETER
55 granted patents·15 pending applications·1,427 citations·filing 1978–2022
99Inventor score
Top patents by PatentIndex Score
70 records- 0197US6107301A1N-alkyl-N-arylpyrimidinamines and derivatives thereofDU PONT PHARM CO·Filed 1997·Granted Aug 22, 2000·192 cites·9 claims
- 0297US4886431APeristaltic pump having independently adjustable cartridgesCOLE PARMER INSTR CO·Filed 1988·Granted Dec 12, 1989·191 cites·12 claims
- 0396US7067507B2Macrocycles useful in the treatment of Alzheimer's diseaseUPJOHN CO·Filed 2002·Granted Jun 27, 2006·235 cites·35 claims
- 0494US7541357B2Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotoninAMR TECHNOLOGY INC·Filed 2005·Granted Jun 2, 2009·24 cites·37 claims
- 0594US7419985B24-Phenyl substituted tetrahydroisoquinolines and therapeutic use thereofAMR TECHNOLOGY INC·Filed 2005·Granted Sep 2, 2008·23 cites·38 claims
- 0694US7176242B2N,N′-substituted-1,3-diamino-2-hydroxypropane derivativesUPJOHN CO·Filed 2002·Granted Feb 13, 2007·92 cites·20 claims
- 0793US7084152B24-phenyl substituted tetrahydroisoquinolines therapeutic use thereofAMR TECHNOLOGY INC·Filed 2001·Granted Aug 1, 2006·41 cites·30 claims
- 0893US6448261B1Arylamino fused pyridinesBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted Sep 10, 2002·55 cites·9 claims
- 0992US6579885B2Aryl and heteroaryl substituted tetrahydroisoquinolines and use thereofALBANY MOLECULAR RES INC·Filed 2002·Granted Jun 17, 2003·50 cites·25 claims
- 1092US4323478ANovel particulate compositionsBAXTER TRAVENOL LAB·Filed 1979·Granted Apr 6, 1982·30 cites·10 claims
- 1191US7309789B24-phenyl substituted tetrahydroisoquinolines and therapeutic use thereofAMR TECHNOLOGY INC·Filed 2006·Granted Dec 18, 2007·18 cites·8 claims
- 1290US7163949B14-phenyl substituted tetrahydroisoquinolines and use thereofAMR TECHNOLOGY INC·Filed 2000·Granted Jan 16, 2007·26 cites·38 claims
- 1389US8236796B2Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotoninMOLINO BRUCE F·Filed 2009·Granted Aug 7, 2012·10 cites·46 claims
- 1489US8227486B2Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotoninMOLINO BRUCE F·Filed 2008·Granted Jul 24, 2012·10 cites·19 claims
- 1589US7727997B2N,N′-substituted-1,3-diamino-2-hydroxypropane derivativesELAN PHARM INC·Filed 2006·Granted Jun 1, 2010·21 cites·27 claims
- 1689US4211015AMethod and apparatus for making novel particulate compositionsBAXTER TRAVENOL LAB·Filed 1978·Granted Jul 8, 1980·23 cites·25 claims
- 1786US6642230B2Imidazopyrimidines and imidazopyridines for the treatment of neurological disordersBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Nov 4, 2003·22 cites·5 claims
- 1886US6525056B2Heterocyclyl-substituted ring-fused pyridines and pyrimidines as corticotropin releasing hormone (CRH) antagonists, useful for treating cns and stress-related disordersBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Feb 25, 2003·22 cites·16 claims
- 1982US7612090B2Aryl and heteroaryl substituted tetrahydroisoquinolines and use thereofALBANY MOLECULAR RES INC·Filed 2003·Granted Nov 3, 2009·15 cites·8 claims
- 2082US7244725B2Acetyl 2-hydroxy-1, 3-diaminoalkanesUPJOHN CO·Filed 2003·Granted Jul 17, 2007·16 cites·14 claims
- 2182US7214715B2Compounds to treat Alzheimer's diseaseELAN PHARM INC·Filed 2001·Granted May 8, 2007·18 cites·100 claims
- 2281US9499531B2Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotoninALBANY MOLECULAR RES INC·Filed 2015·Granted Nov 22, 2016·2 cites·6 claims
- 2381US6143743AImidazopyrimidines and imidazopyridines for the treatment of neurological disordersDU PONT PHARM CO·Filed 1998·Granted Nov 7, 2000·41 cites·8 claims
- 2480US7902356B2Thiazolopyridinone derivates as MCH receptor antagonistsLILLY CO ELI·Filed 2005·Granted Mar 8, 2011·6 cites·11 claims
- 2580US7265116B2Aryl and heteroaryl substituted tetrahydroisoquinolines and use thereofARM TECHNOLOGY INC·Filed 2004·Granted Sep 4, 2007·17 cites·30 claims
- 2680US6846813B2Compounds to treat alzheimer's diseaseUPJOHN CO·Filed 2001·Granted Jan 25, 2005·10 cites·72 claims
- 2778US11298231B2Percutaneous osseointegrated implant assembly for use in supporting an exo-prosthesisUNIV UTAH RES FOUND·Filed 2019·Granted Apr 12, 2022·2 cites·19 claims
- 2877US6969709B2Macrocycles useful in the treatment of Alzheimer's diseaseUPJOHN CO·Filed 2002·Granted Nov 29, 2005·7 cites·33 claims
- 2977US6174912B1Nitrogen substituted imidazo[4,5-C]pyrazoles as corticotropin releasing hormone antagonistsDU PONT PHARM CO·Filed 1998·Granted Jan 16, 2001·21 cites·11 claims
- 3076US6107300AArylamino fused pyrimidinesDU PONT PHARM CO·Filed 1997·Granted Aug 22, 2000·35 cites·9 claims
- 3175US12064350B2Percutaneous osseointegrated implant assembly for use in supporting an exo-prosthesisUNIV UTAH RES FOUND·Filed 2022·Granted Aug 20, 2024·0 cites·20 claims
- 3274US6124300AAryloxy- and arylthio- fused pyridines and pyrimidines and derivativesDU PONT PHARM CO·Filed 1997·Granted Sep 26, 2000·32 cites·15 claims
- 3371US7645780B2Acetyl 2-hydroxy-1, 3-diaminoalkanesELAN PHARM INC·Filed 2006·Granted Jan 12, 2010·1 cites·14 claims
- 3470US6245769B1Heterocyclyl-substituted ring-fused pyridines and pyrimidines as corticotropin releasing hormone(CRH) antagonists, useful for treating CNS and stress-related disordersDU PONT PHARM CO·Filed 1998·Granted Jun 12, 2001·25 cites·15 claims
- 3569US7045529B2Imidazopyrimidinyl and imidazopyri dinyl derivativesBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted May 16, 2006·4 cites·21 claims
- 3667US9668889B2Percutaneous osseointegrated prosthetic implant systemHOLT BRIAN MUELLER·Filed 2012·Granted Jun 6, 2017·8 cites·11 claims
- 3764US9085531B2Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotoninALBANY MOLECULAR RES INC·Filed 2014·Granted Jul 21, 2015·0 cites·14 claims
- 3863US2008318997A1Novel 4-phenyl substituted tetrahydroisoquinolines and therapeutic use thereofAMR TECHNOLOGY INC·Filed 2008·Application pending·0 cites
- 3961US8889856B2Tetrahydropyrrolothiazine compoundsLILLY CO ELI·Filed 2014·Granted Nov 18, 2014·0 cites·8 claims
- 4061US6362180B1Imidazopyridines for the treatment of neurological disordersBRISTOL MYERS SQUIBB PHARMA CO·Filed 1998·Granted Mar 26, 2002·14 cites·2 claims
- 4161US6124463ABenzimidazoles as corticotropin release factor antagonistsDU PONT PHARM CO·Filed 1999·Granted Sep 26, 2000·21 cites·8 claims
- 4261US2023075772A1Implantable bone scaffolds including at least one integration aid, methods of making and using the sameUNIV UTAH RES FOUND·Filed 2022·Application pending·0 cites
- 4360US8772282B2Tetrahydropyrrolothiazine compoundsLILLY CO ELI·Filed 2013·Granted Jul 8, 2014·0 cites·12 claims
- 4460US8741901B2Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotoninMOLINO BRUCE F·Filed 2012·Granted Jun 3, 2014·0 cites·13 claims
- 4559US2009291970A1Substituted Aminoethers for the Treatment of Alzheimer's DiseaseELAN PHARM INC·Filed 2009·Application pending·0 cites
- 4658US7262208B2Hydroxypropyl amides for the treatment of Alzheimer's diseaseUPJOHN CO·Filed 2003·Granted Aug 28, 2007·2 cites·6 claims
- 4758US6103737AAryl- and arylamino- substituted heterocycles as corticotropin releasing hormone antagonistsDU PONT PHARM CO·Filed 1998·Granted Aug 15, 2000·15 cites·7 claims
- 4858US2010145056A1Acetyl 2-hydroxy-1,3-diaminoalkanesJOHN VARGHESE·Filed 2009·Application pending·0 cites
- 4954US9433505B2Percutaneous osseointegrated implant assembly for use in supporting an exo-prosthesisUNIV UTAH RES FOUND·Filed 2014·Granted Sep 6, 2016·0 cites·17 claims
- 5054US2006148803A1Substituted peptides useful in the treatment of alzheimer's diseasePHARMACIA & UPJOHN CO LLC·Filed 2003·Application pending·0 cites
Showing the top 50 of 70 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →